HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Rebecca C Fitzgerald Selected Research

Cyclin A

11/2015Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus.
1/2015The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.
1/2007Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.
11/2004Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Rebecca C Fitzgerald Research Topics

Disease

22Adenocarcinoma
09/2015 - 07/2003
19Barrett Esophagus (Barrett's Esophagus)
09/2015 - 07/2003
16Neoplasms (Cancer)
09/2015 - 06/2005
5Stomach Neoplasms (Stomach Cancer)
07/2014 - 01/2006
3Aneuploidy (Aneuploid)
11/2015 - 01/2005
2Carcinoma (Carcinomatosis)
07/2010 - 11/2004
2Disease Progression
02/2010 - 02/2009
2Metaplasia
02/2010 - 07/2007
1Tetraploidy
01/2015
1Signet Ring Cell Carcinoma
07/2014
1Esophageal Neoplasms (Esophageal Cancer)
12/2013
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2013
1Obesity
04/2010
1Pathologic Constriction (Stenosis)
01/2010
1Neoplasm Metastasis (Metastasis)
01/2007
1Inflammation
09/2005

Drug/Important Bio-Agent (IBA)

9Aminocaproic Acids (EAC)FDA LinkGeneric
09/2015 - 09/2005
8Biological Markers (Surrogate Marker)IBA
06/2015 - 11/2007
4Cyclin AIBA
11/2015 - 11/2004
4Cadherins (E-Cadherin)IBA
07/2010 - 01/2006
3DNA (Deoxyribonucleic Acid)IBA
07/2013 - 06/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2010 - 10/2007
2MicroRNAs (MicroRNA)IBA
01/2015 - 12/2013
2Phenobarbital (Luminal)FDA Link
09/2010 - 10/2007
2Transforming Growth Factor beta (TGF-beta)IBA
02/2010 - 01/2007
2Histones (Histone)IBA
02/2009 - 11/2004
2VimentinIBA
07/2007 - 10/2006
2imidazole mustard (BIC)IBA
01/2007 - 09/2005
2Cyclin D1IBA
01/2005 - 11/2004
2GastrinsIBA
07/2004 - 12/2003
1Oxytocin (Pitocin)FDA LinkGeneric
01/2015
1trefoil factorIBA
01/2015
1Phosphotransferases (Kinase)IBA
10/2013
1tyrosine receptor (receptor, tyrosine)IBA
10/2013
1Transcription Factors (Transcription Factor)IBA
04/2012
1LectinsIBA
02/2012
1PolysaccharidesIBA
02/2012
1Tissue Inhibitor of Metalloproteinases (TIMP)IBA
09/2010
1Tissue Inhibitor of Metalloproteinase-1IBA
09/2010
1tebufenozide (Mimic)IBA
09/2010
1AntigensIBA
06/2010
1Virulence Factors (Pathogenicity Factors)IBA
06/2010
1Cytokine Receptors (Cytokine Receptor)IBA
02/2010
1Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
01/2010
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
02/2009
1decitabine (5-aza-2'-deoxycytidine)FDA Link
02/2009
1ChromatinIBA
02/2009
1Carbon MonoxideIBA
07/2007
1Peptide Hydrolases (Proteases)IBA
01/2007
1Plasminogen Activator Inhibitor 1IBA
01/2007
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2007
1Keratin-18 (Keratin 18)IBA
10/2006
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
09/2005
1CytokinesIBA
09/2005
1Cyclin B1IBA
11/2004
1Messenger RNA (mRNA)IBA
07/2004
1Proteins (Proteins, Gene)IBA
07/2003

Therapy/Procedure

2Gastrectomy
07/2014 - 07/2010
2Esophagectomy
01/2014 - 01/2013
1Photochemotherapy (Photodynamic Therapy)
01/2010
1Argon Plasma Coagulation
01/2010
1Therapeutics
07/2008